CINQAIR
NDC 59310-610, Reslizumab, injection, solution, concentrate, from Teva Respiratory, LLC.
- Product NDC
- 59310-610
- Status
- Listed
- Labeler
- Teva Respiratory, LLC
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761033
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59310-610 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RESLIZUMAB10 mg/mL
Pharmacologic classes
Interleukin-5 Antagonist [EPC]; Interleukin-5 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59310-610-31 | 59310061031 | 1 VIAL, SINGLE-USE in 1 CARTON (59310-610-31) / 10 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/053b9158-2a5b-48b9-bf47-5fa78a35ec33Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=59310-610
Use it
Look up 59310-610 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59310-610 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59310-610. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.